[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MX2020009584A - Fosfatos y boronatos de piridinona y pirimidinona utiles como agentes antibacterianos. - Google Patents

Fosfatos y boronatos de piridinona y pirimidinona utiles como agentes antibacterianos.

Info

Publication number
MX2020009584A
MX2020009584A MX2020009584A MX2020009584A MX2020009584A MX 2020009584 A MX2020009584 A MX 2020009584A MX 2020009584 A MX2020009584 A MX 2020009584A MX 2020009584 A MX2020009584 A MX 2020009584A MX 2020009584 A MX2020009584 A MX 2020009584A
Authority
MX
Mexico
Prior art keywords
sup
boronates
pyrimidinone
pyridinone
phosphates
Prior art date
Application number
MX2020009584A
Other languages
English (en)
Inventor
Matthew Frank Brown
Ye Che
Justin Ian Montgomery
Anthony Marfat
Michael Joseph Melnick
Timothy Allan Johnson
Richard Andrew Ewin
Daniel Uccello
Usa Reilly
Tamim Fehme Braish
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MX2020009584A publication Critical patent/MX2020009584A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/095—Compounds containing the structure P(=O)-O-acyl, P(=O)-O-heteroatom, P(=O)-O-CN
    • C07F9/097—Compounds containing the structure P(=O)-O-N
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/69—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C07D249/06—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/04—Esters of boric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/58—Pyridine rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención está dirigida a nuevos fosfatos de ácido hidroxámico de piridinona o pirimidinona de la Fórmula (1) y boronatos de la Fórmula (2), estereoisómeros de los mismos; (ver Fórmulas) en donde Q se selecciona del grupo que consiste en -P(O)(OH)2, -P(O)(OH)(O-M+), -P(O)(O-M+)2 y -P(O)(O-)2M2+; M+ en cada caso es un catión monovalente farmacéuticamente aceptable; y M2+ es un catión divalente farmacéuticamente aceptable; X es CH o N; y Z es como se define en la presente descripción; y su uso como inhibidores de la LpxC y, más específicamente, su uso para tratar infecciones bacterianas.
MX2020009584A 2018-03-15 2019-03-14 Fosfatos y boronatos de piridinona y pirimidinona utiles como agentes antibacterianos. MX2020009584A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862643286P 2018-03-15 2018-03-15
PCT/US2019/022170 WO2019178305A1 (en) 2018-03-15 2019-03-14 Pyridinone and pyrimidinone phosphates and boronates useful as antibacterial agents

Publications (1)

Publication Number Publication Date
MX2020009584A true MX2020009584A (es) 2020-10-05

Family

ID=65952126

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020009584A MX2020009584A (es) 2018-03-15 2019-03-14 Fosfatos y boronatos de piridinona y pirimidinona utiles como agentes antibacterianos.

Country Status (10)

Country Link
US (1) US20210017206A1 (es)
EP (1) EP3765027A1 (es)
JP (1) JP2021518351A (es)
CN (1) CN111867600A (es)
AU (1) AU2019235870A1 (es)
BR (1) BR112020017453A2 (es)
CA (1) CA3092327A1 (es)
MX (1) MX2020009584A (es)
RU (1) RU2754177C1 (es)
WO (1) WO2019178305A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023192356A1 (en) 2022-03-30 2023-10-05 Zoetis Services Llc Intermediates useful for the preparation of an lpxc analog, and processes for their preparation
CN118021802B (zh) * 2024-02-28 2024-08-30 上海陶术生物科技有限公司 化合物0683-0042作为ndm-1抑制剂在抗菌中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2057127B1 (en) * 2006-08-31 2012-01-11 Schering Corporation Hydantoin derivatives useful as antibacterial agents
WO2008105515A1 (ja) * 2007-02-28 2008-09-04 Taisho Pharmaceutical Co., Ltd. 新規なヒドロキサム酸誘導体
WO2010100475A1 (en) * 2009-03-02 2010-09-10 Astrazeneca Ab Hydroxamic acid derivatives as gram-negative antibacterial agents
JP5793766B2 (ja) * 2009-12-16 2015-10-14 ファイザー・インク 抗菌剤として有用なｎ−結合型ヒドロキサム酸誘導体
AU2012226473B8 (en) * 2011-03-07 2015-10-15 Pfizer Inc. Fluoro-pyridinone derivatives useful as antibacterial agents
EP2847168A1 (en) * 2012-05-10 2015-03-18 Achaogen, Inc. Antibacterial agents
WO2014160649A1 (en) * 2013-03-29 2014-10-02 Novartis Ag Hydroxamic acid derivatives as lpxc inhibitors for the treatment of bacterial infections
US10189786B2 (en) * 2013-08-16 2019-01-29 Duke University Antibacterial compounds
WO2019175828A1 (en) * 2018-03-15 2019-09-19 Pfizer Inc. Fluoro-pyridinone phosphates and boronates useful as antibacterial agents

Also Published As

Publication number Publication date
US20210017206A1 (en) 2021-01-21
WO2019178305A8 (en) 2020-10-29
JP2021518351A (ja) 2021-08-02
CA3092327A1 (en) 2019-09-19
CN111867600A (zh) 2020-10-30
BR112020017453A2 (pt) 2020-12-22
AU2019235870A1 (en) 2020-09-03
RU2754177C1 (ru) 2021-08-30
WO2019178305A1 (en) 2019-09-19
EP3765027A1 (en) 2021-01-20

Similar Documents

Publication Publication Date Title
AU2018274723A1 (en) Benzimidazolone derived inhibitors of BCL6
GEP20237561B (en) Protein tyrosine phosphatase inhibitors
MX2018014358A (es) Composiciones antimicrobianas.
MX341977B (es) Derivados de fluoro-piridinona utiles como agentes antibacterianos.
MX2020002825A (es) Beta-hidroxietilaminas heteroaril sustituidas para su uso en el tratamiento de hiperglucemia.
MX2022016515A (es) Nuevo inhibidor de la secrecion de acido y uso del mismo.
MX2013011526A (es) Derivados de isoxazol utiles como agentes antibacteriales .
MX2020009584A (es) Fosfatos y boronatos de piridinona y pirimidinona utiles como agentes antibacterianos.
JO3818B1 (ar) مركبات حمض أيزوكسازول هيدروكساميك على هيئة مثبطات LpxC
AR084863A1 (es) Inhibidores de girasa y topoisomerasa iv utiles para tratar infecciones bacterianas y composiciones farmaceuticas que los contienen
TN2017000076A1 (en) N-alkylaryl-5-oxyaryl-octahydro-cyclopenta[c]pyrrole negative allosteric modulators of nr2b
UY25780A1 (es) Nuevos antibióticos macrólidos
EA201692189A1 (ru) Соединения фосфина золота (i) в качестве антибактериальных агентов
MX2021010700A (es) Compuestos utiles en la terapia del vih.
MX2022005024A (es) Profarmacos de fosforo de estimuladores de guanilato ciclasa soluble (sgc).
PH12017500057A1 (en) Arylhydrazides containing a 2-pyridone moeity as selective antibacterial agents
MX2022000164A (es) Inhibidores de tirosina cinasa no receptora 1 (tnk1) y usos de los mismos.
MX2021001564A (es) Diazabiciclooctanonas como inhibidores de serina beta-lactamasas.
SG11201810725WA (en) Novel β-lactamase inhibitors
PH12018500066A1 (en) Pyridine compounds
EA201992370A1 (ru) Соединения и способы для лечения бактериальных инфекций
MX2021003294A (es) Compuestos de isoxazol carboxamida y usos de los mismos.
MX2023002525A (es) Nuevos compuestos.
EA202290215A1 (ru) Соединения и способы их применения в качестве антибактериальных агентов
MX2018000635A (es) Composiciones para el cuidado bucal.